Overview of vertebrate animal models of fungal infection

Journal of Immunological Methods

Volumn 410, Issue , 2014, Pages 100-112

  Hohl, Tobias M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Animal model; Fungus; Immune response; Mouse; Pathogenesis; Yeast

Indexed keywords

ANTIFUNGAL AGENT;

ANIMAL MODEL; APPARENT LIFE THREATENING EVENT; EXPERIMENTAL ANIMAL; FUNGAL STRAIN; IMMUNE RESPONSE; MYCOSIS; NONHUMAN; PATHOGENESIS; REVIEW; SYSTEMIC MYCOSIS; VERTEBRATE; ANIMAL; DISEASE MODEL; FUNGUS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; YEAST;

ANIMAL MODEL; FUNGUS; IMMUNE RESPONSE; MOUSE; PATHOGENESIS; YEAST;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MYCOSES;

EID: 84908502490     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.03.022     Document Type: Review

References (151)

1. Achterman R.R., White T.C. A foot in the door for dermatophyte research. PLoS Pathog. 2012, 8:e1002564.
2. Achterman R.R., Smith A.R., Oliver B.G., White T.C. Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model. Fungal Genet. Biol. 2011, 48:335-341.
3. Balloy V., Huerre M., Latge J.P., Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect. Immun. 2005, 73:494-503.
4. Bar E., Gladiator A., Bastidas S., Roschitzki B., Acha-Orbea H., Oxenius A., LeibundGut-Landmann S. A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J. Immunol. 2012, 188:5636-5643.
5. Blackwell M. The fungi: 1, 2, 3... 5.1million species?. Am. J. Bot. 2011, 98:426-438.
6. Bowman J.C., Abruzzo G.K., Anderson J.W., Flattery A.M., Gill C.J., Pikounis V.B., Schmatz D.M., Liberator P.A., Douglas C.M. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 2001, 45:3474-3481.
7. Brito M.M., Conceicao-Silva F., Morgado F.N., Raibolt P.S., Schubach A., Schubach T.P., Schaffer G.M., Borba C.M. Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model. Med. Mycol. 2007, 45:721-729.
8. Brock M., Jouvion G., Droin-Bergere S., Dussurget O., Nicola M.A., Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl. Environ. Microbiol. 2008, 74:7023-7035.
9. Brothers K.M., Wheeler R.T. Non-invasive imaging of disseminated candidiasis in zebrafish larvae. J. Vis. Exp. 2012, e4051.
10. Brothers K.M., Newman Z.R., Wheeler R.T. Live imaging of disseminated candidiasis in zebrafish reveals role of phagocyte oxidase in limiting filamentous growth. Eukaryot. Cell 2011, 10:932-944.
11. Brothers K.M., Gratacap R.L., Barker S.E., Newman Z.R., Norum A., Wheeler R.T. NADPH oxidase-driven phagocyte recruitment controls Candida albicans filamentous growth and prevents mortality. PLoS Pathog. 2013, 9:e1003634.
12. Brown G.D. Innate antifungal immunity: the key role of phagocytes. Annu. Rev. Immunol. 2011, 29:1-21.
13. Brown G.D., Denning D.W., Gow N.A., Levitz S.M., Netea M.G., White T.C. Hidden killers: human fungal infections. Sci. Transl. Med. 2012, 4:165rv13.
14. Brummer E., Restrepo A., Stevens D.A., Azzi R., Gomez A.M., Hoyos G.L., McEwen J.G., Cano L.E., de Bedout C. Murine model of paracoccidioidomycosis. Production of fatal acute pulmonary or chronic pulmonary and disseminated disease: immunological and pathological observations. J. Exp. Pathol. 1984, 1:241-255.
15. Byrnes E.J., Bartlett K.H., Perfect J.R., Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect. 2011, 13:895-907.
16. Cai Y., Kimura S. Noninvasive intratracheal intubation to study the pathology and physiology of mouse lung. J. Vis. Exp. 2013, e50601.
17. Calich V.L., Singer-Vermes L.M., Siqueira A.M., Burger E. Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br. J. Exp. Pathol. 1985, 66:585-594.
18. Charoenvit Y., Taylor R.L. Experimental sporotrichosis in Syrian hamsters. Infect. Immun. 1979, 23:366-372.
19. Chiller T.M., Luque J.C., Sobel R.A., Farrokhshad K., Clemons K.V., Stevens D.A. Development of a murine model of cerebral aspergillosis. J. Infect. Dis. 2002, 186:574-577.
20. Clemons K.V., Stevens D.A. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med. Mycol. 2005, 43(Suppl. 1):S101-S110.
21. Clemons K.V., Stevens D.A. Conventional or molecular measurement of Aspergillus load. Med. Mycol. 2009, 47(Suppl. 1):S132-S137.
22. Clemons K.V., Capilla J., Stevens D.A. Experimental animal models of coccidioidomycosis. Ann. N. Y. Acad. Sci. 2007, 1111:208-224.
23. Connolly P., Wheat L.J., Schnizlein-Bick C., Durkin M., Kohler S., Smedema M., Goldberg J., Brizendine E., Loebenberg D. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob. Agents Chemother. 2000, 44:2604-2608.
24. Day J.N., Chau T.T., Lalloo D.G. Combination antifungal therapy for cryptococcal meningitis. N. Engl. J. Med. 2013, 368:2522-2523.
25. De Ravin S.S., Zarember K.A., Long-Priel D., Chan K.C., Fox S.D., Gallin J.I., Kuhns D.B., Malech H.L. Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease. Blood 2010, 116:1755-1760.
26. de Repentigny L. Animal models in the analysis of Candida host-pathogen interactions. Curr. Opin. Microbiol. 2004, 7:324-329.
27. Deepe G.S., Romani L., Calich V.L., Huffnagle G., Arruda C., Molinari-Madlum E.E., Perfect J.R. Knockout mice as experimental models of virulence. Med. Mycol. 2000, 38(Suppl. 1):87-98.
28. Dei-Cas E., Brun-Pascaud M., Bille-Hansen V., Allaert A., Aliouat E.M. Animal models of pneumocystosis. FEMS Immunol. Med. Microbiol. 1998, 22:163-168.
29. Desalermos A., Fuchs B.B., Mylonakis E. Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog. 2012, 8:e1002451.
30. Desoubeaux G., Chandenier J. A nebulized intra-tracheal rat model of invasive pulmonary aspergillosis. Methods Mol. Biol. 2012, 845:511-518.
31. Ding J.C., Bauer M., Diamond D.M., Leal M.A., Johnson D., Williams B.K., Thomas A.M., Najvar L., Graybill J.R., Larsen R.A. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Antimicrob. Agents Chemother. 1997, 41:1589-1593.
32. Dixon D.M., Polak A., Walsh T.J. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect. Immun. 1989, 57:1452-1456.
33. Doyle T.C., Nawotka K.A., Kawahara C.B., Francis K.P., Contag P.R. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Microb. Pathog. 2006, 40:82-90.
34. Drew R.H., Townsend M.L., Pound M.W., Johnson S.W., Perfect J.R. Recent advances in the treatment of life-threatening, invasive fungal infections. Expert. Opin. Pharmacother. 2013, 14:2361-2374.
35. Fidel P.L., Lynch M.E., Sobel J.D. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 1993, 61:1990-1995.
36. Fisher M.C., Henk D.A., Briggs C.J., Brownstein J.S., Madoff L.C., McCraw S.L., Gurr S.J. Emerging fungal threats to animal, plant and ecosystem health. Nature 2012, 484:186-194.
37. Fuchs B.B., Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr. Opin. Microbiol. 2006, 9:346-351.
38. Grahl N., Puttikamonkul S., Macdonald J.M., Gamcsik M.P., Ngo L.Y., Hohl T.M., Cramer R.A. In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis. PLoS Pathog. 2011, 7:e1002145.
39. Graybill J.R., Najvar L.K., Gonzalez G.M., Hernandez S., Bocanegra R. Improving the mouse model for studying the efficacy of voriconazole. J. Antimicrob. Chemother. 2003, 51:1373-1376.
40. Gudlaugsson O., Gillespie S., Lee K., Vande Berg J., Hu J., Messer S., Herwaldt L., Pfaller M., Diekema D. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 2003, 37:1172-1177.
41. Harriott M.M., Lilly E.A., Rodriguez T.E., Fidel P.L., Noverr M.C. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 2010, 156:3635-3644.
42. Hasenberg M., Köhler A., Bonifatius S., Jeron A., Gunzer M. Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy. J. Vis. Exp. 2011, 52:e2659. 10.3791/2659.
43. Havlickova B., Czaika V.A., Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008, 51(Suppl. 4):2-15.
44. Hay R.J., Calderon R.A., Collins M.J. Experimental dermatophytosis: the clinical and histopathologic features of a mouse model using Trichophyton quinckeanum (mouse favus). J. Investig. Dermatol. 1983, 81:270-274.
45. Heitman J. Microbial pathogens in the fungal kingdom. Fungal Biol. Rev. 2011, 25:48-60.
46. Helms M.N., Torres-Gonzalez E., Goodson P., Rojas M. Direct Tracheal Instillation of Solutes into Mouse Lung. J. Vis. Exp. 2010, 42:e1941. 10.3791/1941.
47. Hoselton S.A., Samarasinghe A.E., Seydel J.M., Schuh J.M. An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice. Med. Mycol. 2010, 48:1056-1065.
48. Iliev I.D., Funari V.A., Taylor K.D., Nguyen Q., Reyes C.N., Strom S.P., Brown J., Becker C.A., Fleshner P.R., Dubinsky M., Rotter J.I., Wang H.L., McGovern D.P., Brown G.D., Underhill D.M. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336:1314-1317.
49. Jhingran A., Mar K.B., Kumasaka D.K., Knoblaugh S.E., Ngo L.Y., Segal B.H., Iwakura Y., Lowell C.A., Hamerman J.A., Lin X., Hohl T.M. Tracing conidial fate and measuring host cell antifungal activity using a reporter of microbial viability in the lung. Cell Rep. 2012, 2:1762-1773.
50. Kainer M.A., Reagan D.R., Nguyen D.B., Wiese A.D., Wise M.E., Ward J., Park B.J., Kanago M.L., Baumblatt J., Schaefer M.K., Berger B.E., Marder E.P., Min J.Y., Dunn J.R., Smith R.M., Dreyzehner J., Jones T.F. Fungal infections associated with contaminated methylprednisolone in Tennessee. N. Engl. J. Med. 2012, 367:2194-2203. Tennessee Fungal Meningitis Investigation T.
51. Kamberi P., Sobel R.A., Clemons K.V., Stevens D.A., Pappagianis D., Williams P.L. A murine model of coccidioidal meningitis. J. Infect. Dis. 2003, 187:453-460.
52. Kamei K. Animal models of zygomycosis-Absidia, Rhizopus, Rhizomucor, and Cunninghamella. Mycopathologia 2001, 152:5-13.
53. Kelly M.M., McNagny K., Williams D.L., van Rooijen N., Maxwell L., Gwozd C., Mody C.H., Kubes P. The lung responds to zymosan in a unique manner independent of toll-like receptors, complement, and dectin-1. Am. J. Respir. Cell Mol. Biol. 2008, 38:227-238.
54. Kenyon C., Bonorchis K., Corcoran C., Meintjes G., Locketz M., Lehloenya R., Vismer H.F., Naicker P., Prozesky H., van Wyk M., Bamford C., du Plooy M., Imrie G., Dlamini S., Borman A.M., Colebunders R., Yansouni C.P., Mendelson M., Govender N.P. A dimorphic fungus causing disseminated infection in South Africa. N. Engl. J. Med. 2013, 369:1416-1424.
55. Kirkpatrick W.R., Najvar L.K., Bocanegra R., Patterson T.F., Graybill J.R. New guinea pig model of Cryptococcal meningitis. Antimicrob. Agents Chemother. 2007, 51:3011-3013.
56. Koga H. Animal model for superficial mycosis. Nihon Ishinkin Gakkai Zasshi 2009, 50:85-89.
57. Koh A.Y., Kohler J.R., Coggshall K.T., Van Rooijen N., Pier G.B. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 2008, 4:e35.
58. Kudeken N., Kawakami K., Kusano N., Saito A. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 1996, 34:371-378.
59. Kupfahl C., Heinekamp T., Geginat G., Ruppert T., Hartl A., Hof H., Brakhage A.A. Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model. Mol. Microbiol. 2006, 62:292-302.
60. Kurup V.P., Mauze S., Choi H., Seymour B.W., Coffman R.L. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol. 1992, 148:3783-3788.
61. La Hoz R.M., Baddley J.W. Subcutaneous fungal infections. Curr. Infect. Dis. Rep. 2012, 14:530-539.
62. Lanternier F., Cypowyj S., Picard C., Bustamante J., Lortholary O., Casanova J.L., Puel A. Primary immunodeficiencies underlying fungal infections. Curr. Opin. Pediatr. 2013, 25:736-747.
63. Leal S.M., Cowden S., Hsia Y.C., Ghannoum M.A., Momany M., Pearlman E. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog. 2010, 6:e1000976.
64. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8:630-638.
65. Lin L., Ibrahim A.S., Xu X., Farber J.M., Avanesian V., Baquir B., Fu Y., French S.W., Edwards J.E., Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009, 5:e1000703.
66. Lionakis M.S. Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology. Virulence 2011, 2:521-527.
67. Lionakis M.S., Kontoyiannis D.P. Drosophila melanogaster as a model organism for invasive aspergillosis. Methods Mol. Biol. 2012, 845:455-468.
68. Lionakis M.S., Lim J.K., Lee C.C., Murphy P.M. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J. Innate Immun. 2011, 3:180-199.
69. Lionakis M.S., Swamydas M., Fischer B.G., Plantinga T.S., Johnson M.D., Jaeger M., Green N.M., Masedunskas A., Weigert R., Mikelis C., Wan W., Lee C.C., Lim J.K., Rivollier A., Yang J.C., Laird G.M., Wheeler R.T., Alexander B.D., Perfect J.R., Gao J.L., Kullberg B.J., Netea M.G., Murphy P.M. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J. Clin. Invest. 2013, 123:5035-5051.
70. Liu M., Spellberg B., Phan Q.T., Fu Y., Fu Y., Lee A.S., Edwards J.E., Filler S.G., Ibrahim A.S. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J. Clin. Invest. 2010, 120:1914-1924.
71. MacCallum D.M. Mouse intravenous challenge models and applications. Methods Mol. Biol. 2012, 845:499-509.
72. MacCallum D.M. Mouse model of invasive fungal infection. Methods Mol. Biol. 2013, 1031:145-153.
73. MacCallum D.M., Odds F.C. Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs. J. Antimicrob. Chemother. 2002, 50:219-224.
74. Machholz E., Mulder G., Ruiz C., Corning B.F., Pritchett-Corning K.R. Manual Restraint and Common Compound Administration Routes in Mice and Rats. J. Vis. Exp. 2012, 67:e2771. 10.3791/2771.
75. Majer O., Bourgeois C., Zwolanek F., Lassnig C., Kerjaschki D., Mack M., Muller M., Kuchler K. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog. 2012, 8:e1002811.
76. Marakalala M.J., Vautier S., Potrykus J., Walker L.A., Shepardson K.M., Hopke A., Mora-Montes H.M., Kerrigan A., Netea M.G., Murray G.I., Maccallum D.M., Wheeler R., Munro C.A., Gow N.A., Cramer R.A., Brown A.J., Brown G.D. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog. 2013, 9:e1003315.
77. McEwen J.G., Bedoya V., Patino M.M., Salazar M.E., Restrepo A. Experimental murine paracoccidiodomycosis induced by the inhalation of conidia. J. Med. Vet. Mycol. 1987, 25:165-175.
78. Mosci P., Pericolini E., Gabrielli E., Kenno S., Perito S., Bistoni F., d'Enfert C., Vecchiarelli A. A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice. Virulence 2013, 4:250-254.
79. Muhammed M., Coleman J.J., Mylonakis E. Caenorhabditis elegans: a nematode infection model for pathogenic fungi. Methods Mol. Biol. 2012, 845:447-454.
80. Muhammed M., Feldmesser M., Shubitz L.F., Lionakis M.S., Sil A., Wang Y., Glavis-Bloom J., Lewis R.E., Galgiani J.N., Casadevall A., Kontoyiannis D.P., Mylonakis E. Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus. Virulence 2012, 3:329-338.
81. Naglik J.R., Fidel P.L., Odds F.C. Animal models of mucosal Candida infection. FEMS Microbiol. Lett. 2008, 283:129-139.
82. Najvar L.K., Bocanegra R., Graybill J.R. An alternative animal model for comparison of treatments for cryptococcal meningitis. Antimicrob. Agents Chemother. 1999, 43:413-414.
83. Nett J.E., Marchillo K., Spiegel C.A., Andes D.R. Development and validation of an in vivo Candida albicans biofilm denture model. Infect. Immun. 2010, 78:3650-3659.
84. Nett J.E., Marchillo K., Andes D.R. Modeling of fungal biofilms using a rat central vein catheter. Methods Mol. Biol. 2012, 845:547-556.
85. Ngamskulrungroj P., Chang Y., Sionov E., Kwon-Chung K.J. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. mBio 2012, 3.
86. Ngo L.Y., Kasahara S., Kumasaka D.K., Knoblaugh S.E., Jhingran A., Hohl T.M. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 2014, 209:109-119.
87. Nobile C.J., Fox E.P., Nett J.E., Sorrells T.R., Mitrovich Q.M., Hernday A.D., Tuch B.B., Andes D.R., Johnson A.D. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 2012, 148:126-138.
88. Paisley D., Robson G.D., Denning D.W. Correlation between in vitro growth rate and in vivo virulence in Aspergillus fumigatus. Med. Mycol. 2005, 43:397-401.
89. Pande K., Chen C., Noble S.M. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat. Genet. 2013, 45:1088-1091.
90. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
91. Patterson T.F. The future of animal models of invasive aspergillosis. Med. Mycol. 2005, 43(Suppl. 1):S115-S119.
92. Petraitiene R., Petraitis V., Groll A.H., Sein T., Schaufele R.L., Francesconi A., Bacher J., Avila N.A., Walsh T.J. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary Aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob. Agents Chemother. 2002, 46:12-23.
93. Rahman D., Mistry M., Thavaraj S., Naglik J.R., Challacombe S.J. Murine model of concurrent oral and vaginal Candida albicans colonisation. Methods Mol. Biol. 2012, 845:527-535.
94. Rayamajhi M., Redente E.F., Condon T.V., Gonzalez-Juarrero M., Riches D.W., Lenz L.L. Non-surgical Intratracheal Instillation of Mice with Analysis of Lungs and Lung Draining Lymph Nodes by Flow Cytometry. J. Vis. Exp. 2011, 51:e2702. 10.3791/2702.
95. Reddy A.T., Lakshmi S.P., Reddy R.C. Murine model of allergen induced asthma. J. Vis. Exp. 2012, e3771.
96. Reinhardt D.J., Licata I., Kaplan W., Ajello L., Chandler F.W., Ellis J.J. Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among zygomycetes. Sabouraudia 1981, 19:245-256.
97. Rhodes J.C. Aspergillus fumigatus: growth and virulence. Med. Mycol. 2006, 44(Suppl. 1):S77-S81.
98. Rhodes J.C., Wicker L.S., Urba W.J. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 1980, 29:494-499.
99. Rivera A., Ro G., Van Epps H.L., Simpson T., Leiner I., Sant'Angelo D.B., Pamer E.G. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity 2006, 25:665-675.
100. Rivera A., Hohl T.M., Collins N., Leiner I., Gallegos A., Saijo S., Coward J.W., Iwakura Y., Pamer E.G. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J. Exp. Med. 2011, 208:369-381.
101. Rizzetto L., Giovannini G., Bromley M., Bowyer P., Romani L., Cavalieri D. Strain dependent variation of immune responses to A. fumigatus: definition of pathogenic species. PLoS One 2013, 8:e56651.
102. Rodriguez T.E., Falkowski N.R., Harkema J.R., Huffnagle G.B. Role of neutrophils in preventing and resolving acute fungal sinusitis. Infect. Immun. 2007, 75:5663-5668.
103. Romani L., Fallarino F., De Luca A., Montagnoli C., D'Angelo C., Zelante T., Vacca C., Bistoni F., Fioretti M.C., Grohmann U., Segal B.H., Puccetti P. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008, 451:211-215.
104. Sable C.A., Strohmaier K.M., Chodakewitz J.A. Advances in antifungal therapy. Annu. Rev. Med. 2008, 59:361-379.
105. Saijo S., Ikeda S., Yamabe K., Kakuta S., Ishigame H., Akitsu A., Fujikado N., Kusaka T., Kubo S., Chung S.H., Komatsu R., Miura N., Adachi Y., Ohno N., Shibuya K., Yamamoto N., Kawakami K., Yamasaki S., Saito T., Akira S., Iwakura Y. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010, 32:681-691.
106. Samaranayake Y.H., Samaranayake L.P. Experimental oral candidiasis in animal models. Clin. Microbiol. Rev. 2001, 14:398-429.
107. Samarasinghe A.E., Hoselton S.A., Schuh J.M. A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice. Fungal Biol. 2011, 115:21-29.
108. Saunte D.M., Hasselby J.P., Brillowska-Dabrowska A., Frimodt-Moller N., Svejgaard E.L., Linnemann D., Nielsen S.S., Haedersdal M., Arendrup M.C. Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungals. Med. Mycol. 2008, 46:303-313.
109. Savage D.C., Dubos R.J. Localization of indigenous yeast in the murine stomach. J. Bacteriol. 1967, 94:1811-1816.
110. Shah A., Sachdev A., Coggon D., Hossain P. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br. J. Ophthalmol. 2011, 95:762-767.
111. Shao X., Mednick A., Alvarez M., van Rooijen N., Casadevall A., Goldman D.L. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J. Immunol. 2005, 175:3244-3251.
112. Sheppard D.C., Rieg G., Chiang L.Y., Filler S.G., Edwards J.E., Ibrahim A.S. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 2004, 48:1908-1911.
113. Sheppard D.C., Graybill J.R., Najvar L.K., Chiang L.Y., Doedt T., Kirkpatrick W.R., Bocanegra R., Vallor A.C., Patterson T.F., Filler S.G. Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 2006, 50:3501-3503.
114. Sheppard D.C., Marr K.A., Fredricks D.N., Chiang L.Y., Doedt T., Filler S.G. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin. Microbiol. Infect. 2006, 12:376-380.
115. Shibuya K., Takaoka M., Uchida K., Wakayama M., Yamaguchi H., Takahashi K., Paris S., Latge J.P., Naoe S. Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants. Microb. Pathog. 1999, 27:123-131.
116. Smith R.M., Schaefer M.K., Kainer M.A., Wise M., Finks J., Duwve J., Fontaine E., Chu A., Carothers B., Reilly A., Fiedler J., Wiese A.D., Feaster C., Gibson L., Griese S., Purfield A., Cleveland A.A., Benedict K., Harris J.R., Brandt M.E., Blau D., Jernigan J., Weber J.T., Park B.J. Fungal infections associated with contaminated methylprednisolone injections. N. Engl. J. Med. 2013, 369:1598-1609. Multistate Fungal Infection Outbreak Response, T.
117. Smulian A.G. Invasive models of histoplasmosis. Methods Mol. Biol. 2012, 845:519-525.
118. Solis N.V., Filler S.G. Mouse model of oropharyngeal candidiasis. Nat. Protoc. 2012, 7:637-642.
119. Sorensen K.N., Clemons K.V., Stevens D.A. Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis. Mycopathologia 1999, 146:53-65.
120. Sousa Mda G., Reid D.M., Schweighoffer E., Tybulewicz V., Ruland J., Langhorne J., Yamasaki S., Taylor P.R., Almeida S.R., Brown G.D. Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe 2011, 9:436-443.
121. Spellberg B., Ibrahim A.S., Edwards J.E., Filler S.G. Mice with disseminated candidiasis die of progressive sepsis. J. Infect. Dis. 2005, 192:336-343.
122. Spikes S., Xu R., Nguyen C.K., Chamilos G., Kontoyiannis D.P., Jacobson R.H., Ejzykowicz D.E., Chiang L.Y., Filler S.G., May G.S. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J. Infect. Dis. 2008, 197:479-486.
123. Steele C., Wormley F.L. Immunology of fungal infections: lessons learned from animal models. Curr. Opin. Microbiol. 2012, 15:413-419.
124. Steinbach W.J., Benjamin D.K., Trasi S.A., Miller J.L., Schell W.A., Zaas A.K., Foster W.M., Perfect J.R. Value of an inhalational model of invasive aspergillosis. Med. Mycol. 2004, 42:417-425.
125. Steinbach W.J., Marr K.A., Anaissie E.J., Azie N., Quan S.P., Meier-Kriesche H.U., Apewokin S., Horn D.L. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J. Infect. 2012, 65:453-464.
126. Stephens-Romero S.D., Mednick A.J., Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect. Immun. 2005, 73:114-125.
127. Stevens D.A. Animal models of blastomycosis. Semin. Respir. Infect. 1997, 12:196-197.
128. Sugar A.M., Liu X.P. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Med. Mycol. 2000, 38:209-212.
129. Sugui J.A., Pardo J., Chang Y.C., Zarember K.A., Nardone G., Galvez E.M., Mullbacher A., Gallin J.I., Simon M.M., Kwon-Chung K.J. Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot. Cell 2007, 6:1562-1569.
130. Sun Y., Chandra J., Mukherjee P., Szczotka-Flynn L., Ghannoum M.A., Pearlman E. A murine model of contact lens-associated Fusarium keratitis. Invest. Ophthalmol. Vis. Sci. 2010, 51:1511-1516.
131. Tang C.M., Cohen J., Krausz T., Van Noorden S., Holden D.W. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect. Immun. 1993, 61:1650-1656.
132. Tarabishy A.B., Aldabagh B., Sun Y., Imamura Y., Mukherjee P.K., Lass J.H., Ghannoum M.A., Pearlman E. MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J. Immunol. 2008, 181:593-600.
133. Thompson G.R., Wiederhold N.P., Najvar L.K., Bocanegra R., Kirkpatrick W.R., Graybill J.R., Patterson T.F. A murine model of Cryptococcus gattii meningoencephalitis. J. Antimicrob. Chemother. 2012, 67:1432-1438.
134. Tobin D.M., May R.C., Wheeler R.T. Zebrafish: a see-through host and a fluorescent toolbox to probe host-pathogen interaction. PLoS Pathog. 2012, 8:e1002349.
135. Torres-Rodriguez J.M., Morera Y., Baro T., Corominas J.M., Castaneda E. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model. Med. Mycol. 2003, 41:59-63.
136. Tsai N.Y., Laforce-Nesbitt S.S., Tucker R., Bliss J.M. A murine model for disseminated candidiasis in neonates. Pediatr. Res. 2011, 69:189-193.
137. Van Cutsem J. Animal models for dermatomycotic infections. Curr. Top. Med. Mycol. 1989, 3:1-35.
138. Van Cutsem J., Janssen P.A. Experimental systemic dermatophytosis. J. Investig. Dermatol. 1984, 83:26-31.
139. Waldorf A.R., Halde C., Vedros N.A. Murine model of pulmonary mucormycosis in cortisone-treated mice. Sabouraudia 1982, 20:217-224.
140. Walsh T.J., Garrett K., Feurerstein E., Girton M., Allende M., Bacher J., Francesconi A., Schaufele R., Pizzo P.A. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrob. Agents Chemother. 1995, 39:1065-1069.
141. Wang H., Lebert V., Hung C.Y., Galles K., Saijo S., Lin X., Cole G.T., Klein B.S., Wuthrich M. C-type lectin receptors differentially induce Th17 cells and vaccine immunity to the endemic mycosis of North America. J. Immunol. 2014, 192:1107-1119.
142. Wheat L.J., Kohler R.B., Tewari R.P. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 1986, 314:83-88.
143. Williams J.E., Moser S.A. Chronic murine pulmonary blastomycosis induced by intratracheally inoculated Blastomyces dermatitidis conidia. Am. Rev. Respir. Dis. 1987, 135:17-25.
144. Williams P.L., Sobel R.A., Sorensen K.N., Clemons K.V., Shuer L.M., Royaltey S.S., Yao Y., Pappagianis D., Lutz J.E., Reed C., River M.E., Lee B.C., Bhatti S.U., Stevens D.A. A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit. J. Infect. Dis. 1998, 178:1217-1221.
145. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 2004, 39:309-317.
146. Wuthrich M., Filutowicz H.I., Klein B.S. Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J. Clin. Invest. 2000, 106:1381-1389.
147. Wuthrich M., Gern B., Hung C.Y., Ersland K., Rocco N., Pick-Jacobs J., Galles K., Filutowicz H., Warner T., Evans M., Cole G., Klein B. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J. Clin. Invest. 2011, 121:554-568.
148. Wuthrich M., Hung C.Y., Gern B.H., Pick-Jacobs J.C., Galles K.J., Filutowicz H.I., Cole G.T., Klein B.S. A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J. Immunol. 2011, 187:1421-1431.
149. Wuthrich M., Deepe G.S., Klein B. Adaptive immunity to fungi. Annu. Rev. Immunol. 2012, 30:115-148.
150. Zaragoza O., Alvarez M., Telzak A., Rivera J., Casadevall A. The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect. Immun. 2007, 75:2729-2739.
151. Zhu L.L., Zhao X.Q., Jiang C., You Y., Chen X.P., Jiang Y.Y., Jia X.M., Lin X. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 2013, 39:324-334.